SCHEMBL3561876

SCHEMBL3561876

Cc1ccccc1C(=O)Nc1ccccc1OCCOc1ccc(C(=O)O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.54
TDP1 Q9NUW8 1/20 0.54
PLK1 P53350 1/20 0.53
PKM P14618 1/20 0.52
ALDH1A1 P00352 3/20 0.52
KMT2A Q03164 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
LMNA P02545 2/20 0.52
RAB9A P51151 2/20 0.52
MEN1 O00255 2/20 0.52
NPC1 O15118 1/20 0.52
CACNA1H O95180 2/20 0.52
CACNA1B Q00975 2/20 0.52
GAA P10253 2/20 0.48
MAPT P10636 2/20 0.48
POLB P06746 1/20 0.48
HPGD P15428 1/20 0.48
ALOX12 P18054 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
PTPN1 P18031 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3554389 0.88 KMT2A (0.57) L3MBTL1PLK1PKMALDH1A1KMT2A
SCHEMBL3558462 0.87 PKM (0.54) L3MBTL1TDP1PLK1PKMALDH1A1
SCHEMBL3563105 0.86 L3MBTL1 (0.60) L3MBTL1TDP1PLK1PKMALDH1A1
SCHEMBL3560773 0.86 PKM (0.52) PLK1PKMALDH1A1KMT2ASMN1; SMN2
SCHEMBL3555876 0.86 CACNA1H (0.57) PLK1PKMALDH1A1KMT2ASMN1; SMN2
SCHEMBL3559976 0.85 PKM (0.60) L3MBTL1PLK1PKMKMT2ASMN1; SMN2
SCHEMBL3557989 0.83 F10 (0.62) L3MBTL1PLK1PKMALDH1A1KMT2A
SCHEMBL3554988 0.81 GAA (0.57) L3MBTL1PLK1PKMALDH1A1KMT2A
SCHEMBL3556306 0.81 RAB9A (0.56) L3MBTL1PLK1PKMALDH1A1KMT2A
SCHEMBL3565241 0.81 KMT2A (0.57) PLK1PKMKMT2ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US claimed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US claimed
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US disclosed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes SLC5A1, ALDH7A1, ASS1 L3MBTL1 2080/4885TDP1 2267/4885PLK1 4876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.